Respiratory syncytial virus infection causes substantial illness in older adults. A bivalent RSV prefusion F vaccine is under investigation to reduce RSV-associated respiratory illness.
New research findings are summarized in this short video.
To see full article, follow this link: https://nej.md/40zX0xf